Modulations of SIRTUINs and Management of Brain Disorders-Reference-Cited by-同舟云学术

Modulations of SIRTUINs and Management of Brain Disorders

Published:2023-03-08 Issue: Volume: Page:47-81
ISSN:
Container-title:Traditional Medicine for Neuronal Health
language:
Short-container-title:

Author:

Shekhar Sudhir Kumar¹,Siddiqui Sarfraj Ahmad²,Rai Girish³

Affiliation:

1. King George Medical University,Department of Biochemistry,Lucknow,India,226003,

2. University of Lucknow,Department of Zoology,Lucknow,India,226007,

3. Vivekanand Government PG College Maihar,Manpur,India,485771,

Abstract

Neurodegenerative disorders are the conditions in which neurons of the central and peripheral nervous systems degenerate. Various cellular and molecular processes are associated with the progression of such degeneration, including inflammation, apoptosis, and axonal degeneration. Recently, SIRTUINs have emerged as one of the key factors associated with neurodegenerative disorders. SIRTUINs are involved in the regulation of several cellular and molecular processes in neurons of the nervous system through the deacetylation of target proteins. The chapter focuses on the modulatory role of SIRTUINs in neurodegenerative disorders and their potential therapeutic application. <br>

Publisher

BENTHAM SCIENCE PUBLISHERS

Reference148 articles.

1. Gan L.; Mucke L.; Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 2008,58(1),10-14

2. Donmez G.; Arun A.; Chung C.Y.; McLean P.J.; Lindquist S.; Guarente L.; SIRT1 protects against α-synuclein aggregation by activating molecular chaperones. J Neurosci 2012,32(1),124-132

3. Herskovits A.Z.; Guarente L.; SIRT1 in neurodevelopment and brain senescence. Neuron 2014,81(3),471-483

4. Vaquero A.; Sternglanz R.; Reinberg D.; NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs. Oncogene 2007,26(37),5505-5520

5. Houtkooper R.H.; Cantó C.; Wanders R.J.; Auwerx J.; The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 2010,31(2),194-223